Newfound Research LLC Insulet Corp Transaction History

Newfound Research LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$194.8 - $275.7 $63,699 - $90,153	-327 Closed	0 $0
Q4 2021 Jan 19, 2022	BUY	$255.32 - $318.29 $83,489 - $104,080	327 New	327 $87,000
Q2 2021 Jul 19, 2021	SELL	$225.52 - $304.06 $55,928 - $75,406	-248 Closed	0 $0
Q1 2021 Apr 28, 2021	SELL	$235.95 - $293.05 $1,415 - $1,758	-6 Reduced 2.36%	248 $65,000
Q4 2020 Jan 22, 2021	BUY	$215.97 - $265.89 $25,916 - $31,906	120 Added 89.55%	254 $65,000
Q3 2020 Oct 20, 2020	BUY	$192.55 - $236.59 $25,801 - $31,703	134 New	134 $32,000

685

62.7M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.2B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Newfound Research LLC, based on Form 13F filings with the SEC.

Stay updated on Newfound Research LLC with notifications on news.